Picture of Arix Bioscience logo

ARIX Arix Bioscience News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall CapMomentum Trap

Brief: Arix Bioscience Says Aura Reported Positive Phase 1B/2 Clinical Data For AU-011

Oct 30 (Reuters) - Arix Bioscience PLC  ARIX.L :
    * REG-ARIX BIOSCIENCE PLC: AURA BIOSCIENCES REPORTS POSITIVE
PHASE
1B/2 DATA
    * ARIX BIOSCIENCE PLC - AURA BIOSCIENCES REPORTS POSITIVE
PHASE
1B/2 CLINICAL DATA FOR AU-011
    * ARIX BIOSCIENCE PLC - AURA SAYS ALL PATIENTS MET
PRELIMINARY
EFFICACY ENDPOINT TO DATE WITH EVIDENCE OF BIOLOGICAL ACTIVITY
    * ARIX BIOSCIENCE PLC - AURA PLANS TO INITIATE A PIVOTAL
PHASE 3
CLINICAL STUDY

Source text for Eikon:  ID:nPRrUF3A9a 
Further company coverage:  ARIX.L 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Arix Bioscience

See all news